AGL 40.00 Decreased By ▼ -0.01 (-0.02%)
AIRLINK 127.06 Decreased By ▼ -0.93 (-0.73%)
BOP 6.64 Increased By ▲ 0.04 (0.61%)
CNERGY 4.54 Decreased By ▼ -0.06 (-1.3%)
DCL 8.58 Increased By ▲ 0.10 (1.18%)
DFML 41.70 Increased By ▲ 0.22 (0.53%)
DGKC 87.40 Increased By ▲ 0.82 (0.95%)
FCCL 32.59 Increased By ▲ 0.45 (1.4%)
FFBL 64.87 Decreased By ▼ -0.55 (-0.84%)
FFL 10.24 Decreased By ▼ -0.01 (-0.1%)
HUBC 109.35 Decreased By ▼ -1.14 (-1.03%)
HUMNL 14.65 Decreased By ▼ -0.10 (-0.68%)
KEL 5.11 Decreased By ▼ -0.02 (-0.39%)
KOSM 7.57 Increased By ▲ 0.45 (6.32%)
MLCF 41.65 No Change ▼ 0.00 (0%)
NBP 59.61 Decreased By ▼ -0.48 (-0.8%)
OGDC 193.01 Decreased By ▼ -1.68 (-0.86%)
PAEL 28.16 Increased By ▲ 0.21 (0.75%)
PIBTL 7.82 Decreased By ▼ -0.18 (-2.25%)
PPL 151.45 Increased By ▲ 0.28 (0.19%)
PRL 27.17 Increased By ▲ 0.29 (1.08%)
PTC 16.05 Increased By ▲ 0.05 (0.31%)
SEARL 86.02 Increased By ▲ 7.82 (10%)
TELE 7.75 Increased By ▲ 0.36 (4.87%)
TOMCL 35.51 Decreased By ▼ -0.16 (-0.45%)
TPLP 8.17 Increased By ▲ 0.26 (3.29%)
TREET 16.40 Increased By ▲ 0.51 (3.21%)
TRG 53.34 Increased By ▲ 0.58 (1.1%)
UNITY 26.25 Decreased By ▼ -0.30 (-1.13%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 9,924 Increased By 4.1 (0.04%)
BR30 30,788 Increased By 37 (0.12%)
KSE100 93,643 Increased By 418 (0.45%)
KSE30 29,034 Increased By 148.7 (0.51%)

imageNEW YORK: All three US facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any US government effort to scale up a treatment for Ebola.

The facilities, called Centres for Innovation in Advanced Development and Manufacturing (ADM), were set up by the US Department of Health and Human Services in partnership with private industry, to respond to pandemics or chemical, biological, radiological, or nuclear threats.

They have the expertise to quickly switch production lines to manufacture, for example, a smallpox vaccine if that scourge were to re-emerge, or an anthrax vaccine, and other life-saving compounds against both natural outbreaks and bioterrorism.

"They know our number and they can call us 24 hours a day," said Brett Giroir, chief executive of Texas A&M Health Science Centre, site of one of the facilities. "We are prepared."

Global health agencies are only starting to consider whether to make experimental drugs, most of which have only been tested on monkeys, available to patients in West Africa, which is suffering the worst Ebola outbreak in history.

The World Health Organization is convening a group of bioethicists to consider such as issues as who decides which patients would receive the treatments or vaccines.

US officials have repeatedly emphasized the importance of public health measures such as quarantines to stop the spread of the disease.

Comments

Comments are closed.